Sling Therapeutics
Developing oral therapies for thyroid eye disease
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Sling Therapeutics is a biopharmaceutical company developing treatments for thyroid eye disease. Its lead pipeline program, linsitinib, is in late-stage development as an oral therapy for TED. The company is based in Ann Arbor, Michigan.
- Website
- slingtx.com
- Location
- Ann Arbor, Michigan
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Linsitinib — Oral therapy candidate for thyroid eye disease · Other